José Vidal-Martínez

1.6k total citations
13 papers, 107 citations indexed

About

José Vidal-Martínez is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, José Vidal-Martínez has authored 13 papers receiving a total of 107 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 5 papers in Pulmonary and Respiratory Medicine and 4 papers in Cancer Research. Recurrent topics in José Vidal-Martínez's work include Cancer Cells and Metastasis (6 papers), Cancer Genomics and Diagnostics (4 papers) and Lung Cancer Research Studies (4 papers). José Vidal-Martínez is often cited by papers focused on Cancer Cells and Metastasis (6 papers), Cancer Genomics and Diagnostics (4 papers) and Lung Cancer Research Studies (4 papers). José Vidal-Martínez collaborates with scholars based in Spain, United States and Germany. José Vidal-Martínez's co-authors include Rafael Gisbert‐Criado, Óscar Juan, José Muñoz-Langa, José Gómez‐Codina, Francisco Martínez‐Soriano, Remedios Giner‐Durán, José Hernández-Yago, Rafael Blesa, F. Losa Gaspà and Emilio Esteban and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Hepatology and Annals of Oncology.

In The Last Decade

José Vidal-Martínez

11 papers receiving 106 citations

Peers

José Vidal-Martínez
Christiane Kuempers Germany
Franziska Gabler Germany
Xiaolong Cheng China
Joana L. Mora United States
Kristof Cuppens Belgium
Rajya Kappagantula United States
Tiffany M. Delhomme France
Haihua Fu China
Susanna Nguy United States
Filippo Giovanardi Italy
Christiane Kuempers Germany
José Vidal-Martínez
Citations per year, relative to José Vidal-Martínez José Vidal-Martínez (= 1×) peers Christiane Kuempers

Countries citing papers authored by José Vidal-Martínez

Since Specialization
Citations

This map shows the geographic impact of José Vidal-Martínez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by José Vidal-Martínez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites José Vidal-Martínez more than expected).

Fields of papers citing papers by José Vidal-Martínez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by José Vidal-Martínez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by José Vidal-Martínez. The network helps show where José Vidal-Martínez may publish in the future.

Co-authorship network of co-authors of José Vidal-Martínez

This figure shows the co-authorship network connecting the top 25 collaborators of José Vidal-Martínez. A scholar is included among the top collaborators of José Vidal-Martínez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with José Vidal-Martínez. José Vidal-Martínez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Llombart‐Cussac, Antonio, María Leonor Fernández-Murga, Eduardo Martínez de Dueñas, et al.. (2025). Circulating tumor DNA (ctDNA)-based minimal residual disease (MRD) measured by Guardant Reveal in patients (pts) with HER2-positive (HER2+) metastatic breast cancer (mBC) with long-term disease control on first-line trastuzumab-pertuzumab.. Journal of Clinical Oncology. 43(16_suppl). 1052–1052. 1 indexed citations
2.
3.
Garde, J., Eloísa Jantus‐Lewintre, José Vidal-Martínez, et al.. (2019). Soluble biomarker signature to predict outcome of patients with non-small-cell lung cancer (NSCLC) treated with anti-PD1/PDL1 monoclonal antibodies.. Journal of Clinical Oncology. 37(15_suppl). e20685–e20685. 1 indexed citations
4.
Morales, Serafín, Ana Velasco, José Vidal-Martínez, et al.. (2018). Circulating tumor cells (CTCs) and cytokeratin 19 (CK19) mRNA as prognostic factors in heavily pretreated patients with metastatic breast cancer. Cancer Treatment and Research Communications. 16. 13–17. 4 indexed citations
5.
Davis, Andrew A., Jean‐Yves Pierga, Luc Dirix, et al.. (2018). The impact of circulating tumor cells (CTCs) detection in metastatic breast cancer (MBC): Implications of “indolent” stage IV disease (Stage IVindolent).. Journal of Clinical Oncology. 36(15_suppl). 1019–1019. 3 indexed citations
6.
Juan, Óscar, José Vidal-Martínez, Remei Blanco, et al.. (2014). Quantification of circulating endothelial cells as a predictor of response to chemotherapy with platinum and pemetrexed in patients with advanced non-squamous non-small cell lung carcinoma. Clinical & Translational Oncology. 17(4). 281–288. 8 indexed citations
7.
Juan, Óscar, et al.. (2013). Prognostic significance of circulating tumor cells in advanced non-small cell lung cancer patients treated with docetaxel and gemcitabine. Clinical & Translational Oncology. 16(7). 637–643. 50 indexed citations
8.
9.
Esteban, Emilio, et al.. (2008). Circulating tumor cells in breast cancer: methodology and clinical repercussions. Clinical & Translational Oncology. 10(7). 399–406. 6 indexed citations
10.
Juan, Óscar, José Muñoz-Langa, D. Almenar, et al.. (2005). Risk model for severe anemia in patients with non-hematologic cancer receiving conventional chemotherapy: Results from a multicenter prospective cohort study. Journal of Clinical Oncology. 23(16_suppl). 8121–8121.
11.
Blesa, Rafael, et al.. (2003). Report of hereditary persistence of α-fetoprotein in a Spanish family: molecular basis and clinical concerns. Journal of Hepatology. 38(4). 541–544. 14 indexed citations
12.
Pumar, José Manuel, et al.. (1996). [Neurinoma of the facial nerve in the stylomastoid foramen: evaluation with CT and MRI].. PubMed. 23(120). 452–3. 1 indexed citations
13.
Vidal-Martínez, José, et al.. (1992). Endoscopic enhancement of the healing of high-risk colon anastomoses by low-power helium-neon laser. Diseases of the Colon & Rectum. 35(6). 568–573. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christiane Kuempers Breakdown of academic impact, for papers by Franziska Gabler Breakdown of academic impact, for papers by Xiaolong Cheng Breakdown of academic impact, for papers by Joana L. Mora Breakdown of academic impact, for papers by Kristof Cuppens Breakdown of academic impact, for papers by Rajya Kappagantula Breakdown of academic impact, for papers by Tiffany M. Delhomme Breakdown of academic impact, for papers by Haihua Fu Breakdown of academic impact, for papers by Susanna Nguy Breakdown of academic impact, for papers by Filippo Giovanardi
Rankless by CCL
2026